165 related articles for article (PubMed ID: 19107340)
1. Microvessel density correlates with lymph node metastases and prognosis in hilar cholangiocarcinoma.
Thelen A; Scholz A; Benckert C; Schröder M; Weichert W; Wiedenmann B; Neuhaus P; Jonas S
J Gastroenterol; 2008; 43(12):959-66. PubMed ID: 19107340
[TBL] [Abstract][Full Text] [Related]
2. Tumor-associated angiogenesis and lymphangiogenesis correlate with progression of intrahepatic cholangiocarcinoma.
Thelen A; Scholz A; Weichert W; Wiedenmann B; Neuhaus P; Gessner R; Benckert C; Jonas S
Am J Gastroenterol; 2010 May; 105(5):1123-32. PubMed ID: 19997097
[TBL] [Abstract][Full Text] [Related]
3. Tumor-associated lymphangiogenesis correlates with lymph node metastases and prognosis in hilar cholangiocarcinoma.
Thelen A; Scholz A; Benckert C; Weichert W; Dietz E; Wiedenmann B; Neuhaus P; Jonas S
Ann Surg Oncol; 2008 Mar; 15(3):791-9. PubMed ID: 18172731
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of VEGF A expression and microvascular density as prognostic factors in extrahepatic cholangiocarcinoma.
Möbius C; Demuth C; Aigner T; Wiedmann M; Wittekind C; Mössner J; Hauss J; Witzigmann H
Eur J Surg Oncol; 2007 Oct; 33(8):1025-9. PubMed ID: 17400419
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-8 is a prognostic indicator in human hilar cholangiocarcinoma.
Sun Q; Li F; Sun F; Niu J
Int J Clin Exp Pathol; 2015; 8(7):8376-84. PubMed ID: 26339407
[TBL] [Abstract][Full Text] [Related]
6. Lymph Node Micrometastases are Associated with Worse Survival in Patients with Otherwise Node-Negative Hilar Cholangiocarcinoma.
Mantel HT; Wiggers JK; Verheij J; Doff JJ; Sieders E; van Gulik TM; Gouw AS; Porte RJ
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1107-15. PubMed ID: 26178761
[TBL] [Abstract][Full Text] [Related]
7. The prognostic significance of microvessel density in intrahepatic cholangiocarcinoma.
Bunsiripaiboon P; Sornmayura P; Wilasrusmee C; Lertsithichai P
J Med Assoc Thai; 2010 Jan; 93(1):66-72. PubMed ID: 20196413
[TBL] [Abstract][Full Text] [Related]
8. TROP2 correlates with microvessel density and poor prognosis in hilar cholangiocarcinoma.
Ning S; Guo S; Xie J; Xu Y; Lu X; Chen Y
J Gastrointest Surg; 2013 Feb; 17(2):360-8. PubMed ID: 23207686
[TBL] [Abstract][Full Text] [Related]
9. [Biopathological characteristics of hilar cholangiocarcinoma and the clinical significance].
Yu WL; Zhang YJ; Dong H; Yu H; Xian ZH; Wu MC; Cong WM
Zhonghua Wai Ke Za Zhi; 2009 Aug; 47(15):1162-6. PubMed ID: 20021908
[TBL] [Abstract][Full Text] [Related]
10. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.
Ito F; Agni R; Rettammel RJ; Been MJ; Cho CS; Mahvi DM; Rikkers LF; Weber SM
Ann Surg; 2008 Aug; 248(2):273-9. PubMed ID: 18650638
[TBL] [Abstract][Full Text] [Related]
11. [Liver transplantation for irresectable hilar cholangiocarcinoma].
Lai Y; Dong J; Duan W; Yu Q; Meng X; Ye S; Zhang D; Huang Z
Zhonghua Wai Ke Za Zhi; 2014 Nov; 52(11):839-44. PubMed ID: 25604023
[TBL] [Abstract][Full Text] [Related]
12. Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases.
Ebata T; Nagino M; Kamiya J; Uesaka K; Nagasaka T; Nimura Y
Ann Surg; 2003 Nov; 238(5):720-7. PubMed ID: 14578735
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of tumor microvessels in intrahepatic cholangiocarcinoma: association with tumor-infiltrating lymphocytes.
Yugawa K; Itoh S; Yoshizumi T; Iseda N; Tomiyama T; Toshima T; Harada N; Kohashi K; Oda Y; Mori M
Mod Pathol; 2021 Apr; 34(4):798-807. PubMed ID: 33077921
[TBL] [Abstract][Full Text] [Related]
14. Surgical treatment and prognostic analysis of 93 cases of hilar cholangiocarcinoma.
Zhang BY; Lu Y; Dong Q; Sun CD; Mu P
Am J Med Sci; 2010 Mar; 339(3):221-4. PubMed ID: 20220331
[TBL] [Abstract][Full Text] [Related]
15. Prognosis after resection for hepatitis B virus-associated intrahepatic cholangiocarcinoma.
Wu ZF; Wu XY; Zhu N; Xu Z; Li WS; Zhang HB; Yang N; Yao XQ; Liu FK; Yang GS
World J Gastroenterol; 2015 Jan; 21(3):935-43. PubMed ID: 25624728
[TBL] [Abstract][Full Text] [Related]
16. [An analysis on prognostic factors of hilar cholangiocarcinoma].
Zhou LX; Zhang ZW; Xu ZY
Zhonghua Yi Xue Za Zhi; 2009 May; 89(18):1275-7. PubMed ID: 19595185
[TBL] [Abstract][Full Text] [Related]
17. Solitary recurrence of hilar cholangiocarcinoma in a mediastinal lymph node two years after curative resection.
Ito Y; Tajima Y; Fujita F; Tsutsumi R; Kuroki T; Kanematsu T
World J Gastroenterol; 2007 Apr; 13(15):2243-6. PubMed ID: 17465511
[TBL] [Abstract][Full Text] [Related]
18. Defining Early Recurrence of Hilar Cholangiocarcinoma After Curative-intent Surgery: A Multi-institutional Study from the US Extrahepatic Biliary Malignancy Consortium.
Zhang XF; Beal EW; Chakedis J; Chen Q; Lv Y; Ethun CG; Salem A; Weber SM; Tran T; Poultsides G; Son AY; Hatzaras I; Jin L; Fields RC; Buettner S; Scoggins C; Martin RCG; Isom CA; Idrees K; Mogal HD; Shen P; Maithel SK; Schmidt CR; Pawlik TM
World J Surg; 2018 Sep; 42(9):2919-2929. PubMed ID: 29404753
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of microvessel density determined by an anti-CD105/endoglin monoclonal antibody in astrocytic tumors: comparison with an anti-CD31 monoclonal antibody.
Yao Y; Kubota T; Takeuchi H; Sato K
Neuropathology; 2005 Sep; 25(3):201-6. PubMed ID: 16193836
[TBL] [Abstract][Full Text] [Related]
20. Microvessel density and angiogenesis in primary hepatic malignancies: Differential expression of CD31 and VEGFR-2 in hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Bösmüller H; Pfefferle V; Bittar Z; Scheble V; Horger M; Sipos B; Fend F
Pathol Res Pract; 2018 Aug; 214(8):1136-1141. PubMed ID: 29935812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
